BAYER AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.32 EUR | -0.96% |
|
+0.93% | -15.80% |
| 10:15am | WDH/Correction/Bayer must pay significantly less in glyphosate case | DP |
| 09:44am | Bayer must pay significantly less in glyphosate case | DP |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
2024-08-06
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
28.6
EUR
Average target price
36.64
EUR
Spread / Average Target
+28.12%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -15.69% | 30.53B | |
| +42.69% | 749B | |
| +38.46% | 605B | |
| -6.87% | 351B | |
| +18.74% | 328B | |
| +6.76% | 292B | |
| +18.68% | 248B | |
| -2.41% | 214B | |
| +11.19% | 216B | |
| +2.64% | 167B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- German Drugmaker Bayer Posts Decline in Q1 Income, Net Sales
